HK1244791A1 - 杂环化合物及它们在预防或治疗细菌感染中的应用 - Google Patents

杂环化合物及它们在预防或治疗细菌感染中的应用 Download PDF

Info

Publication number
HK1244791A1
HK1244791A1 HK18104010.8A HK18104010A HK1244791A1 HK 1244791 A1 HK1244791 A1 HK 1244791A1 HK 18104010 A HK18104010 A HK 18104010A HK 1244791 A1 HK1244791 A1 HK 1244791A1
Authority
HK
Hong Kong
Prior art keywords
formula
nhq
compound
compounds
group
Prior art date
Application number
HK18104010.8A
Other languages
English (en)
Chinese (zh)
Inventor
朱莉．布里亚
朱莉．布里亞
奥德丽．卡拉瓦诺
索菲．查赛特
奧德麗．卡拉瓦諾
弗朗西斯．切弗勒依
法比安．费弗尔
索菲．查賽特
伯诺瓦．勒杜萨尔
弗雷德里克．勒斯塔特
塞巴斯蒂安．理查德
克利斯朵夫．西蒙
法比安．費弗爾
苏菲．沃米思德
伯諾瓦．勒杜薩爾
蘇菲．沃米思德
Original Assignee
拜欧蒂姆公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP15305479.6A external-priority patent/EP3075734A1/en
Application filed by 拜欧蒂姆公司 filed Critical 拜欧蒂姆公司
Publication of HK1244791A1 publication Critical patent/HK1244791A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18104010.8A 2015-03-31 2016-03-30 杂环化合物及它们在预防或治疗细菌感染中的应用 HK1244791A1 (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15305479.6A EP3075734A1 (en) 2015-03-31 2015-03-31 Heterocyclic compounds and their use in preventing or treating bacterial infections
EP15305479.6 2015-03-31
EP16305059 2016-01-22
EP16305059.4 2016-01-22
PCT/EP2016/056845 WO2016156346A1 (en) 2015-03-31 2016-03-30 Heterocyclic compounds and their use in preventing or treating bacterial infections

Publications (1)

Publication Number Publication Date
HK1244791A1 true HK1244791A1 (zh) 2018-08-17

Family

ID=55642466

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18104010.8A HK1244791A1 (zh) 2015-03-31 2016-03-30 杂环化合物及它们在预防或治疗细菌感染中的应用

Country Status (14)

Country Link
US (1) US10570131B2 (https=)
EP (1) EP3277685B1 (https=)
JP (1) JP2018510190A (https=)
KR (1) KR20170131687A (https=)
CN (1) CN107438610A (https=)
AU (1) AU2016239207A1 (https=)
BR (1) BR112017020826A2 (https=)
CA (1) CA2980109A1 (https=)
CL (1) CL2017002449A1 (https=)
HK (1) HK1244791A1 (https=)
MX (1) MX2017012539A (https=)
RU (1) RU2715058C2 (https=)
TW (1) TW201639853A (https=)
WO (2) WO2016156346A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3300736B1 (en) * 2016-09-30 2021-05-05 Mutabilis Composition comprising antibiotic compound and an heterocyclic compound and their use in preventing or treating bacterial infections
EP3357924A1 (en) 2017-02-06 2018-08-08 Mutabilis Novel heterocyclic compounds and their use in preventing or treating bacterial infections
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
EP3833665B1 (en) 2018-08-09 2023-07-19 Antabio SAS Diazabicyclooctanones as inhibitors of serine beta-lactamases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009091856A2 (en) * 2008-01-18 2009-07-23 Merck & Co., Inc. Beta-lactamase inhibitors
MX348974B (es) * 2011-08-27 2017-07-04 Wockhardt Ltd Derivados 1,6 - diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
CA2845108C (en) * 2011-08-30 2015-06-16 Wockhardt Limited 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections
AR090539A1 (es) 2012-04-02 2014-11-19 Astrazeneca Ab COMPUESTOS INHIBIDORES DE b LACTAMASA
HUE046893T2 (hu) 2012-05-30 2020-04-28 Meiji Seika Pharma Co Ltd Új ß-laktamáz inhibitor és eljárás elõállítására
US9271446B2 (en) * 2012-06-28 2016-03-01 Forage Innovations B.V. Self-aligning apparatus and methods for gathering bales
RU2614418C2 (ru) * 2012-08-25 2017-03-28 Вокхардт Лимитед Производные 1,6-диазабицикло[3.2.1]октан-7-она и их применение для лечения бактериальных инфекций
EP2953626A1 (en) * 2013-02-06 2015-12-16 Astrazeneca AB Combination therapy for the treatment of nosocomial pneumonia
WO2014141132A1 (en) * 2013-03-14 2014-09-18 Naeja Pharmaceutical Inc. NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
US10786458B2 (en) 2015-03-31 2020-09-29 Laboratorios Bago S.A. Procedure for preparing enteric-coated pellets containing a proton pump inhibitor and multi-particle pharmaceutical compositions containing them
EP3075733A1 (en) 2015-03-31 2016-10-05 Mutabilis Novel heterocyclic compounds and their use in preventing or treating bacterial infections
GB201505585D0 (en) 2015-03-31 2015-05-13 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
EP3075734A1 (en) * 2015-03-31 2016-10-05 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
MA41850A (fr) 2015-03-31 2018-02-06 Takeda Pharmaceuticals Co Nouvelles utilisations pharmaceutiques

Also Published As

Publication number Publication date
MX2017012539A (es) 2018-09-28
EP3277685B1 (en) 2021-01-13
CL2017002449A1 (es) 2018-04-20
BR112017020826A2 (pt) 2018-07-03
RU2017133745A (ru) 2019-03-28
CN107438610A (zh) 2017-12-05
TW201639853A (zh) 2016-11-16
KR20170131687A (ko) 2017-11-29
WO2016156344A1 (en) 2016-10-06
JP2018510190A (ja) 2018-04-12
WO2016156346A1 (en) 2016-10-06
US10570131B2 (en) 2020-02-25
CA2980109A1 (en) 2016-10-06
RU2017133745A3 (https=) 2019-09-09
EP3277685A1 (en) 2018-02-07
US20180086760A1 (en) 2018-03-29
AU2016239207A1 (en) 2017-10-12
RU2715058C2 (ru) 2020-02-25

Similar Documents

Publication Publication Date Title
CN107438614B (zh) 杂环化合物及它们在预防或治疗细菌感染中的应用
EP3300736B1 (en) Composition comprising antibiotic compound and an heterocyclic compound and their use in preventing or treating bacterial infections
EP3277686B1 (en) Novel heterocyclic compounds and their use in preventing or treating bacterial infections
EP3394071B1 (en) Heterocyclic compounds and their use in preventing or treating bacterial infections
HK1244791A1 (zh) 杂环化合物及它们在预防或治疗细菌感染中的应用
CN112513049B (zh) 杂环化合物及它们在预防或治疗细菌感染中的用途
CN110392684A (zh) 新型杂环化合物及其在预防或治疗细菌感染中的用途
EP3075734A1 (en) Heterocyclic compounds and their use in preventing or treating bacterial infections
EP3075381A1 (en) Heterocyclic compounds and their use in preventing or treating bacterial infections
HK1241877A1 (en) Heterocyclic compounds and their use in preventing or treating bacterial infections
HK40008905A (en) Novel heterocyclic compounds and their use in preventing or treating bacterial infections